Introduction
============

Considering the risk of dental trauma in contact sports, mouthguards are an essential piece of safety gear for athletes to soften impacts and prevent injuries [@R01-2019-0115-0001] [@R01-2019-0115-0026] [@R01-2019-0115-0027] . The American Dental Association recommends the use of MGs in 29 sports [@R01-2019-0115-0005] . The Fédération Dentaire International [@R01-2019-0115-0014] subdivides organized sports into two categories based on the risk of traumatic dental injuries: high-risk sports (such as American football, hockey, ice hockey, lacrosse, martial arts, rugby, inline skating, skateboarding and mountain biking) and medium-risk sports (such as basketball, soccer, handball, squash, gymnastics, parachuting and water polo). Use of an MG is mandatory for rugby players. Nevertheless, 12--37% of rugby players do not use an MG during training or competition [@R01-2019-0115-0008] [@R01-2019-0115-0023] [@R01-2019-0115-0024] [@R01-2019-0115-0028] [@R01-2019-0115-0031] . The major concern is a possible decrease in performance and increase in breathing resistance.

A custom-made MG (MG ~C~ ) is characterized by a better fit and comfort when compared to a boil-and-bite MG [@R01-2019-0115-0006] [@R01-2019-0115-0035] . However due to lower costs, often boil-and-bite MGs are used [@R01-2019-0115-0025] [@R01-2019-0115-0029] . Many players do not use an MG because they expect negative respiratory effects. Recently, an MG with breathing channels was developed (Nike Adult Max Intake, Beaverton, OR, USA). Studies on this type of MG (MG ~V~ ) have been performed by Bailey et al. [@R01-2019-0115-0005] (recreationally trained males using a cycle ergometer) and Schulze et al. [@R01-2019-0115-0032] (basketball specific tests). In these settings ventilation and blood lactate were significantly decreased with MG ~V~ .

The results for oxygen uptake and ventilation at maximum and sub-maximum load for MG ~C~ are inconsistent: five studies reported no differences in either respiratory or cardiac parameters with the MG ~C~ [@R01-2019-0115-0006] [@R01-2019-0115-0009] [@R01-2019-0115-0025] [@R01-2019-0115-0030] [@R01-2019-0115-0035] . Garner et al. [@R01-2019-0115-0017] found significantly higher oxygen uptake and ventilation in constant-load exercise. Two studies showed a significantly improved cycle ergometer performance with an MG ~C~ [@R01-2019-0115-0030] [@R01-2019-0115-0035] . However, no significant differences were found in running performance with an MG ~C~ [@R01-2019-0115-0006] [@R01-2019-0115-0009] [@R01-2019-0115-0025] .

Important elements in rugby are sprint performance and explosive strength. The use of a mouthguard may have positive effects on neuromuscular chains. A mouthguard may facilitate powerful jaw clenching and a subsequent concurrent activation potentiation through a remote voluntary contraction of the mandible muscles [@R01-2019-0115-0002] [@R01-2019-0115-0007] [@R01-2019-0115-0012] . Remote voluntary contractions are a muscle action of the prime mover while performing a simultaneous muscle action with another part of the body [@R01-2019-0115-0012] .

A common disadvantage of all the above-mentioned studies was that the athletes were not accustomed to MG use. The current study is new in three aspects: 1. The subjects were highly trained first-league rugby players who used mouthguards regularly. 2. Typical sports-specific elements were used in a laboratory setting (double incremental treadmill tests, sprints and countermovement jumps) to investigate the mouthguard effects on oxygen uptake, ventilation and blood lactate. 3. Two mouthguard types were compared to no mouthguard use: custom-made mouthguards with an advantage of proper fit, and vented mouthguards with an advantage of specific breathing channels. For coaches and athletes, the study aimed to determine whether a mouthguard with a specific design for improved ventilation would have better physiological responses in comparison to a custom-made mouthguard with a known high level in comfort and protection.

Materials and Methods
=====================

Subjects
--------

The study was approved by the Institutional Review Board and Human Medical Research Committee at the University of Leipzig, Germany (No. 445--15--21122015). Written informed consent was obtained from all participants after they confirmed complete understanding of the study protocol. The study conformed to the Standards for Ethics in Sport and Exercise Science Research [@R01-2019-0115-0022] and required players to provide informed consent before participation. Participants included 13 male subjects between 18 and 34 years old (mean 24.7±4.9 years, height=184.6±5.7 cm, weight=89.25±12.8 kg, BMI=26.25±3 kg/m ^2^ ) who played in the first German rugby league and had a middle position in the league ranking. Exclusion criteria were: acute/chronic infections, antibiotic therapy, chronic/systemic diseases, joint problems, and injuries. In total, 16 players were measured. After 3 dropouts due to sickness or incomplete data acquisition, 13 players were included.

Mouthguards
-----------

The subjects were told that two different kinds of mouthguards would be tested. No information was given about possible advantages or disadvantages in comparison to their personal mouthguards. Two types of mouthguards were used: the vented boil-and-bite mouthguard (MG ~V~ , Nike, Beaverton, OR, USA) and the custom-made mouthguard. The MG ~V~ has patented breathing channels (O-Flow ^TM^ ) designed to improve the ventilation and oxygen uptake during athletic activity ( [Fig. 1](#FI01-2019-0115-0001){ref-type="fig"} ). Compared to traditional mouthguards, these additional air inlets are designed to allow less restricted breathing. The MG ~V~ was placed in boiling water for 30 s and was then carefully placed in the subject's mouth to cover their upper teeth. The subject was instructed to bite down firmly. Moderate pressure was placed on the lips and cheeks for 30 s. The MG ~V~ was then removed and rinsed in cold water.

![Vented mouthguard used in this study (MG ~V~ ).](10-1055-a-0891-7021-i01-2019-0115-0001){#FI01-2019-0115-0001}

The custom-made mouthguard (MG ~C~ ) was vacuum-formed over a stone model that had been prepared from the dental impression (alginate) and a bite registration to adjust an occlusal equilibration ( [Fig. 2](#FI01-2019-0115-0002){ref-type="fig"} ). The thermoforming plate had a thickness of 5 mm (Bioplast Xtreme, Scheu Dental, Iserlohn, Germany).

![Custom-made mouthguard used in this study (MG ~C~ ).](10-1055-a-0891-7021-i01-2019-0115-0002){#FI01-2019-0115-0002}

Lung function measurements
--------------------------

Prior to the exercise tests, a lung function measurement at rest was performed using a tube (Easy on-PC, NDD, Zürich, Schweiz). Vital capacity (VC), forced vital capacity (FVC), peak flow (PEF), and forced 1-second expiratory volume (FEV1) were displayed.

Treadmill protocol
------------------

The subjects performed two subsequent treadmill tests with a 5-minute rest in between (double incremental treadmill exercise, Test A and Test B). In Test A, all spiroergometric data were measured. Test B was used to measure the individual lactate equilibrium (lactate minimum test [@R01-2019-0115-0034] ). In Test A, no lactate samples were taken because the stops for blood sampling would have disturbed the spiroergometric measurements. The treadmill was adjusted to an incline of 1%. Test A began with a 4-minute warm-up (2 min at 6 km/h and 2 min at 8 km/h). Then the load was increased by 1 km/h each minute until exhaustion to produce near-to-ramp increments. During the 5 min recovery, a speed of 6 km/h was maintained. Lactate samples (20 µl) were taken at rest from the hyperaemized ear lobe immediately after Test A and after the first, third, and fifth minute of the break. This break allowed for lactate distribution in the intra- und extracellular space.

In Test B, the running speed was increased by the usual increments of 2 km/h every 2 min until exhaustion. A 5-min. recovery at 6 km/h followed. Lactate was taken after each speed step (at which point the subjects stood on the side bars for 15 s) and after the first, third, and fifth minute of the break. The treadmill tests (n=39) were performed in a randomized order using either no MG, the MG ~V~ or MG ~C~ in the Sports Medicine laboratory at the University of Leipzig.

Exercise testing
----------------

Heart rate (HR), oxygen uptake (VO ~2~ ), ventilation (VE), tidal volume (VT), breathing rate (BR), and carbon dioxide output (VCO ~2~ ) were measured. The spiroergometric data was measured breath-by-breath with a mask (K4b ^2^ , Cosmed, Italy). The VO ~2~ and VCO ~2~ values were calculated from the end-expiratory gas concentrations and VE. VE was calculated as the product of BR and VT. HR was taken from the continuous ECG recording. Super GL (ISO 7550, Germany) was used for the blood lactate measurement.

Sprint and jump protocol
------------------------

Sprint and jump tests are performance markers for team sport athletes. Ten- and forty-meter sprint tests were used to determine acceleration, maximum speed, and anaerobic performance. Countermovement jumps (CMJ) were performed to measure explosive lower-body power performance and explosive strength. Sprint and countermovement tests are generally used by strength and conditioning coaches as differential measurements of speed and strength. For the measurement of sprints and jumps, SmarTrack Diagnostics from Humotion (Münster, Germany) was used. This mobile measuring system consists of a hip belt with an integrated electronic unit. The performance was measured by two modules. The jump module independently detects and records three different jump modes: squat jump (SJ), countermovement jump (CMJ) and drop jump (DJ). The sprint module records the exact running times in the linear sprint. The length of the sprints can be varied by mobile magnetic barriers. A complex sensor system was used to collect the data. The acceleration in all three directions is registered by an acceleration sensor, which also detects the static acceleration due to gravity. The measurement of the movement is performed by a 3-D magnetic field sensor. The speed of the body movement is registered in all three directions via rotational speed sensors. The interaction of all sensors makes it possible to follow the movements of the body or individual body segments.

Prior to the tests, the subjects took part in a standardized warm-up. For the sprint tests the subjects started 1 m before the starting line. After the last sprint, the jump force was measured after a 2 min break. Three consecutive countermovement jumps were then performed with a 1 min break between the jumps. The athletes performed the tests in a randomized order with the MG ~V~ , MG ~C~ , and NoMG. Before testing, the subjects had practice sessions to train for the countermovement jumps.

In all anaerobic tests, the subjects were advised to bite on the MG to ensure an occlusal position [@R01-2019-0115-0021] , but no breathing instructions were given.

Statistical analysis
--------------------

Results are expressed as the means±SD. Data for all variables were tested for and found to be normally distributed using the Shapiro-Wilk test. A repeated-measures ANOVA design was used to assess the statistical significance of differences between the mean values of the different conditions. To confirm differences between groups, Tukey's post hoc test was used. A p-value\<0.05 was considered significant and a p-value\<0.005 was considered highly significant. Also, the 95% confidence interval (CI) was calculated. All analyses were performed using the GraphPadInStat Software (GraphPadSoftware, La Jolla, CA, USA) and the IBM Statistics package software, version 22.0 (IBM SPSS Statistics, Armonk, NY, USA).

Results
=======

Lung function results
---------------------

Peak flow was significantly decreased with MG ~V~ vs. NoMG or MG ~C~ . No mouthguard effects on other lung function parameters were seen ( [Table 1](#TB01-2019-0115-0001){ref-type="table"} ).

###### 

**Table 1** Lung function results (SD in brackets).

                                          NoMG           MG ~V~          MG ~C~         p-value
  --------------------------------------- -------------- --------------- -------------- ----------------------------------------------------
  **VC (l)**                              5.52 (0.62)    5.50 (0.82)     5.40 (0.80)    n.s.
  **FVC (l)**                             5.43 (0.63)    5.37 (0.69)     5.32 (0.61)    n.s.
  **FEV1 (l)**                            4.91 (0.64)    4.80 (0.63)     4.80 (0.63)    n.s.
  **Peak flow (l×s** ^**−1)**^            10.90 (1.84)   9.99 (1.63)\*   10.60 (1.66)   0.002 (NoMG vs. MG ~V~ ) 0.04 (MG ~V~ vs. MG ~C~ )
  **FEF 25--75% of FVC (l×s** ^**−1)**^   5.82 (1.43)    5.64 (1.27)     5.86 (1.66)    n.s.

Treadmill testing results
-------------------------

Compared to NoMG use, the oxygen uptake was moderately, however insignificantly, higher with the MG ~C~ at submaximal and maximum load ( [Table 2](#TB01-2019-0115-0002){ref-type="table"} ). Maximum lactate values were lower when using a mouthguard (MG ~V~ : p\<0.002; MG ~C~ : p\<0.04).

###### 

**Table 2** Exercise results.

  Parameter                                   Intensity        NoMG             MG ~V~                    MG ~C~                     p-value
  ------------------------------------------- ---------------- ---------------- ------------------------- -------------------------- ---------
  **VO** ~**2**~ **(ml×min** ^**−1**^ **)**   sub              4461 (533)       4589 (570)                4697 (530)                 n.s.
  (4139--4783)                                (4245--4934)     (4376--5017)                                                          
  max                                         4541 (575)       4608 (612)       4747 (598)                n.s.                       
  (4193--4888)                                (4238--4978)     (4386--5108)                                                          
  **VCO** ~**2**~ **(l×min** ^**−1**^ **)**   sub              4895 (626)       5042 (611)                5045 (491)                 n.s.
  (4517--5272)                                (4673--5411)     (4748--5342)                                                          
  max                                         5131 (640)       5131 (690)       5159 (646)                n.s.                       
  (4745--5518)                                (4714--5548)     (4769--5549)                                                          
  **HR (bpm)**                                sub              183.8 (7.8)      183.4 (6.6)               182.0 (5.9)                n.s.
  (178.8--188.8)                              (179.2--187.6)   (178.2--185.7)                                                        
  max                                         184.4 (5.9)      183.7 (5.7)      182.6 (6.1)               n.s.                       
  (180.6--188.1)                              (180.1--187.3)   (178.7--186.4)                                                        
  **VE (l×min** ^**−1**^ **)**                sub              135.2 (17.2)     135.6 (16.4)              137.3 (21.1)               n.s.
  (124.8--145.6)                              (125.7--145.5)   128.0--146.6)                                                         
  max                                         143.8 (16.7)     139.5 (18.4)     142.6 (23.7)              n.s.                       
  (133.7--153.9)                              (128.4--150.6)   (128.0--146.6)                                                        
  **BR (breath×min** ^**−1**^ **)**           sub              47.6 (8.2)       46.9 (6.3)                47.6 (5.0)                 n.s.
  (42.6--52.5)                                (43.1--50.7)     (44.5--50.7)                                                          
  max                                         50.7 (6.1)       47.9 (4.7)       49.1 (5.9)                n.s.                       
  (47.0--54.3)                                (45.1--50.8)     (44.5--50.7)                                                          
  **VT (l)**                                  sub              2.92 (0.57)      2.95 (0.53)               2.92 (0.48)                n.s.
  (2.58--3.26)                                (2.63--3.27)     (2.63--3.21)                                                          
  max                                         2.90 (0.54)      2.95 (0.49)      2.94 (0.51)               n.s                        
  (2.57--3.22)                                (2.65--3.24)     (2.63--3.25)                                                          
  **RQ**                                      sub              1.10 (0.10)      1.10 (0.10)               1.08 (0.07)                n.s.
  (1.04--1.16)                                (1.05--1.16)     (1.04--1.12)                                                          
  max                                         1.13 (0.08)      1.12 (0.10)      1.09 (0.09)               n.s.                       
  (1.08--1.18)                                (1.06--1.18)     (1.05--1.13)                                                          
  **FeO** ~**2**~ **(vol%)**                  sub              15.64 (0.61)     15.57 (0.39)              15.63 (0.48)               n.s.
  (15.27--16.01)                              (15.34--15.81)   (15.34--15.92)                                                        
  max                                         15.84 (0.49)     15.57 (0.32)     15.65 (0.50)              n.s.                       
  (15.54--16.13)                              (15.37--15.76)   (15.36--15.94)                                                        
  **FeCO** ~**2**~ **(vol%)**                 sub              5.91 (0.73)      6.00 (0.69)               5.89 (0.60)                n.s.
  (5.48--6.35)                                (5.57--6.40)     (5.53--6.25)                                                          
  max                                         5.85 (0.62)      5.85 (0.81)      5.89 (0.588)              n.s.                       
  (5.47--6.22)                                (5.36--6.35)     (5.53--6.24)                                                          
  **Inspiratory time (s)**                    sub              0.63 (0.10)      0.64 (0.08)               0.61 (0.08)                n.s.
  (0.57--0.69)                                (0.59--0.69)     (0.56--0.66)                                                          
  max                                         0.58 (0.07)      0.62 (0.06)      0.60 (0.08)               n.s.                       
  (0.54--0.62)                                (0.58--0.66)     (0.56--0.65)                                                          
  **Expiratory time (s)**                     sub              0.67 (013)       0.67 (0.11)               0.65 (0.11)                n.s.
  (0.59--0.76)                                (0.60--0.73)     (0.58--0.71)                                                          
  max                                         0.62 (0.10)      0.65 (0.08)      0.64 (0.10)               n.s.                       
  (0.56--0.68)                                (0.60--0.70)     (0.58--0.70)                                                          
  **Velocity (km×h** ^**−1**^ **)**           sub              15.08 (1.32)                                                          
  max                                         15.54 (1.05)     15.38 (1.39)     15.23 (1.36)              n.s.                       
  (14.90--16.17)                              (14.55--16.22)   (14.41--16.05)                                                        
  **Blood lactate (mmol×l** ^**−1**^ **)**    pre              0.85 (0.19)      0.75 (0.14)               0.74 (0.11)                n.s.
  (0.73--0.97)                                (0.66--0.83)     (0.67--0.81)                                                          
  max                                         10.42 (2.27)     8.94 (1.89)\*    9.42 (2.39)\*             0.002 (NoMG vs. MG ~V~ )   
  (9.06--11.79)                               (7.82--10.06)    (7.98--10.86)    0.04 (NoMG vs. MG ~C~ )                              
  **AT** ~**lac**~ **(km×h** ^**−1**^ **)**                    10.6 (1.5)       10.6 (1.5)                10.9 (1.0)                 n.s.
  (9.71--11.52)                               (9.71--11.52)    (10.3--11.55)                                                         

Mean value (SD) and confidence interval in brackets. Maximum values (max): mean values corresponding to the highest speed in each test series (NoMG, MGV, MGC). Submaximum values (sub): mean values corresponding to the series (NoMG, MGV, MGC) with the lowest maximum speed. Pre: pre-exercise values. ATlac (anaerobic lactate threshold): running speed corresponding to the lactate minimum (18) in Test B. \* = significant.

The relation between VO ~2~ and lactate values in all test conditions was significantly higher with the MGs ( [Table 3](#TB01-2019-0115-0003){ref-type="table"} ).

###### 

**Table 3** Metabolic rate in the tests due to the use of mouthguards (SD in brackets).

                   Aerobic kcal×min ^−1^   Anaerobic kcal×min ^−1^   Total kcal×min ^−1^   Aerobic/anaerobic Quotient
  ---------------- ----------------------- ------------------------- --------------------- ----------------------------
  **NoMG**         184.9 (28.07)           12.99 (3.32)              17.25 (1.81)          15.00 (3.60)
  **MG** ~**V**~   178.2 (27.29)           11.11 (2.57)              17.27 (1.75)          16.68 (3.11)
  p\<0.001         p\<0.02                                                                 
  **MG** ~**C**~   185.6 (34.54)           11.78 (3.74)              17.83 (2.45)          16.63 (3.70)
  p\<0.04          p\<0.03                                                                 

P-values refer to the differences between NoMG and MGV or MGC.

Sprint and jump results
-----------------------

The results for the sprints and vertical jumps were almost identical. However, there was a tendency for better sprint times with an MG ( [Table 4](#TB01-2019-0115-0004){ref-type="table"} ).

###### 

**Table 4** Sprint and vertical jump results.

  Test                                   NoMG           MG ~V~       MG ~C~       p-value
  ---------------------- --------------- -------------- ------------ ------------ ---------
  **40 m sprint (s)**    mean            5.44 (0.3)     5.42 (0.3)   5.42 (0.3)   n.s.
  (5.26--5.62)           (5.22--5.62)    (5.24--5.60)                             
  best                   5.39 (0.3)      5.37 (0.4)     5.36 (0.4)   n.s.         
  (5.21--5.57)           (5.16--5.58)    (5.15--5.56)                             
  **10 m sprint (s)**    mean            1.58 (0.1)     1.57 (0.1)   1.58 (0.1)   n.s.
  (1.53--1.63)           (1.53--1.61)    (1.54--1.62)                             
  best                   1.57 (0.1)      1.56 (0.1)     1.56 (0.1)   n.s.         
  (1.52--1.61)           (1.51--1.60)    (1.52--1.60)                             
  **Jump height (cm)**   mean            41.3 (7.5)     41.9 (6.4)   41.5 (7.4)   n.s.
  (36.8--45.9)           (38.0--45.75)   (37.0--46.0)                             
  best                   43.9 (7.7)      44.6 (6.7)     44.0 (7.6)   n.s.         
  (39.4--48.4)           (40.7--48.4)    (39.6--48.3)                             

Means (SD) and confidence interval in brackets.

Discussion
==========

Lung function
-------------

In the current study, only the peak flow was significantly lower with MG ~V~ vs. NoMG or MG ~C~ . No further significant differences in lung function were seen, which is in line with other studies [@R01-2019-0115-0006] [@R01-2019-0115-0010] . However, these conditions do not reflect the game situation because the jaw was fixed in the tests by biting on the mouth tube. When a mask is used instead of a mouth tube, the airflow may be affected even less [@R01-2019-0115-0003] . The increased inspiratory resistance at rest may be reduced in hyperpnea conditions [@R01-2019-0115-0003] . The expiratory airflow can also be affected by the MG thickness and the position of the head, neck and jaw [@R01-2019-0115-0003] . According to Amis et al. [@R01-2019-0115-0003] , the natural flow pattern of the oral cavity may even be positively influenced by the MG ~C~ so that the airflow becomes less turbulent. All these aspects must be considered as a possible cause for the differences between the two MGs regarding expiratory flow and maximum exercise ventilation.

Aerobic and metabolic responses
-------------------------------

In the current study, the maximum blood lactate was significantly lower with MG use (approximately 10% for MG ~V~ and 4% for MG ~C~ , respectively). The blood lactate values are dependent on the anaerobic metabolism and muscle glycogen stores [@R01-2019-0115-0034] . The tests were performed in a randomized order and instructions for nutrition goals were given to refill the glycogen stores. Therefore, different glycogen stores were not expected.

The maximum running speed was almost equal in all tests and there was a tendency toward even higher VO ~2~ values with MG. Theoretically this might indicate slightly reduced energy conversion efficiency. However, lower blood lactate together with a slightly increased VO ~2~ more likely indicates an improved aerobic metabolism due to the MG.

Lower lactate concentrations with MG were also found in other studies [@R01-2019-0115-0005] [@R01-2019-0115-0016] [@R01-2019-0115-0018] [@R01-2019-0115-0032] . Garner and McDivitt [@R01-2019-0115-0016] hypothesized that an increase in the respiration diameter and a resulting increase in CO ~2~ elimination might explain the lower lactate values with MG use. This cannot be confirmed by the current or former results [@R01-2019-0115-0032] , where no differences in CO ~2~ output were measured at maximum load. Bailey et al. [@R01-2019-0115-0005] found significantly lower lactate concentrations at submaximal and maximum load with the MG ~V~ . They assumed that the aerobic energy production might have been improved in the MG ~V~ condition. A possible explanation has been given by Francis and Brasher [@R01-2019-0115-0015] . They hypothesized that the MG might cause a "pursed-lip" type of breathing, which has been shown to decrease CO ~2~ tension, and increase oxygenation and exercise tolerance [@R01-2019-0115-0015] . If this applies, a higher O ~2~ gradient between the alveoli and the lung capillaries might result. This could also explain slightly increased VO ~2~ and decreased blood lactate values as observed in the current study.

Cardiorespiratory responses
---------------------------

Although the peak flow was lower with the MG ~V~ in the current study, maximum VE was similar to NoMG and MG ~C~ . This may indicate that the major effect of the MG ~V~ cannot be attributed to the air channels but to the use of a mouthguard in principle.

HR and VE were similar in all conditions. With respect to recent studies, the type of exercise (ergometer, treadmill, or sports-specific course) may affect the cardiorespiratory response. In the majority of treadmill tests, ventilation was not affected by MG use [@R01-2019-0115-0006] [@R01-2019-0115-0013] [@R01-2019-0115-0019] [@R01-2019-0115-0021] [@R01-2019-0115-0025] . In contrast, VE was lower with MG in cycle ergometer testing [@R01-2019-0115-0005] [@R01-2019-0115-0015] . In a sports-specific environment, VE was lower with MG [@R01-2019-0115-0032] [@R01-2019-0115-0033] . No explanations are provided for the differences in cycle ergometer and treadmill testing. In contrast, in a field setting, the body biomechanics may be different because the jaw may act as a second whole body stabilization area together with the core muscles [@R01-2019-0115-0032] . It is unlikely that this effect plays a role in a laboratory treadmill or cycle ergometer test.

Sprint and jump results
-----------------------

The sprint time over a short distance is an indicator of anaerobic performance. The sprint time was also used to assess the influence of the MG ~C/V~ on anaerobic performance. In the current study, no significant effects were found with both MGs. This is in line with other studies [@R01-2019-0115-0004] [@R01-2019-0115-0005] [@R01-2019-0115-0011] [@R01-2019-0115-0018] [@R01-2019-0115-0020] .

Although the current study did not show any significant differences in the countermovement jumps, the most frequent peak values were seen under the influence of the MG ~V~ . Recent studies reported significant improvements for the CMJ with the MG ~C~ [@R01-2019-0115-0004] [@R01-2019-0115-0011] . Bailey et al. [@R01-2019-0115-0005] found higher vertical jump values with the MG ~V~ . However, as in the current study, most studies did not reveal any significant differences [@R01-2019-0115-0010] [@R01-2019-0115-0011] [@R01-2019-0115-0020] .

The current study is based on treadmill testing, sprints, and countermovement jumps to isolate the specific mouthguard effects. Ventilation was not reduced as seen in handball- and basketball-specific studies [@R01-2019-0115-0032] [@R01-2019-0115-0033] . However, there were also no negative effects on breathing or performance during exercise. The laboratory tests did show an ergogenic effect on the aerobic metabolism. Therefore, for future studies a rugby course will be created and evaluated for sports-specific field testing and then compared to the current laboratory test results in a larger cohort for general implications. Furthermore, studies on the longitudinal effects of the different mouthguard types will be of interest.

Conclusions
===========

Custom-made and vented mouthguards have no negative effects on rugby-specific performance or breathing parameters when tested in a laboratory setting. Maximum exercise capacity, sprints, and jumps are not affected by the use of these two mouthguard types. It is a new observation that aerobic energy turnover may even be improved in rugby-specific motion elements, regardless of whether custom-made or vented mouthguards were used. Presumably, these results can be transferred to authentic game and training situations.
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